1. Home
  2. CLLS vs TZOO Comparison

CLLS vs TZOO Comparison

Compare CLLS & TZOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • TZOO
  • Stock Information
  • Founded
  • CLLS 1999
  • TZOO 1998
  • Country
  • CLLS France
  • TZOO United States
  • Employees
  • CLLS N/A
  • TZOO N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • TZOO Advertising
  • Sector
  • CLLS Health Care
  • TZOO Consumer Discretionary
  • Exchange
  • CLLS Nasdaq
  • TZOO Nasdaq
  • Market Cap
  • CLLS 143.4M
  • TZOO 136.1M
  • IPO Year
  • CLLS 2007
  • TZOO 2002
  • Fundamental
  • Price
  • CLLS $1.58
  • TZOO $12.66
  • Analyst Decision
  • CLLS Buy
  • TZOO Strong Buy
  • Analyst Count
  • CLLS 1
  • TZOO 4
  • Target Price
  • CLLS $4.00
  • TZOO $23.50
  • AVG Volume (30 Days)
  • CLLS 50.1K
  • TZOO 132.7K
  • Earning Date
  • CLLS 08-05-2025
  • TZOO 07-24-2025
  • Dividend Yield
  • CLLS N/A
  • TZOO N/A
  • EPS Growth
  • CLLS N/A
  • TZOO 11.63
  • EPS
  • CLLS N/A
  • TZOO 1.01
  • Revenue
  • CLLS $54,747,000.00
  • TZOO $85,057,000.00
  • Revenue This Year
  • CLLS $48.52
  • TZOO $16.97
  • Revenue Next Year
  • CLLS $5.17
  • TZOO $23.72
  • P/E Ratio
  • CLLS N/A
  • TZOO $12.65
  • Revenue Growth
  • CLLS 351.26
  • TZOO 0.23
  • 52 Week Low
  • CLLS $1.10
  • TZOO $7.12
  • 52 Week High
  • CLLS $2.43
  • TZOO $24.85
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 60.33
  • TZOO 46.08
  • Support Level
  • CLLS $1.41
  • TZOO $12.00
  • Resistance Level
  • CLLS $1.60
  • TZOO $13.65
  • Average True Range (ATR)
  • CLLS 0.09
  • TZOO 0.56
  • MACD
  • CLLS 0.02
  • TZOO 0.03
  • Stochastic Oscillator
  • CLLS 83.52
  • TZOO 32.31

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

Share on Social Networks: